Search by Drug Name or NDC

    NDC 70748-0215-07 NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 20; 375 mg/1; mg/1 Details

    NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 20; 375 mg/1; mg/1

    NAPROXEN AND ESOMEPRAZOLE MAGNESIUM is a ORAL TABLET, DELAYED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is ESOMEPRAZOLE MAGNESIUM; NAPROXEN.

    Product Information

    NDC 70748-0215
    Product ID 70748-215_14b665df-829b-40b0-b381-1f19da5f0bde
    Associated GPIs 66109902440620
    GCN Sequence Number 066329
    GCN Sequence Number Description naproxen/esomeprazole mag TAB IR DR 375MG-20MG ORAL
    HIC3 S2P
    HIC3 Description NSAID,COX INHIBITOR-TYPE AND PROTON-PUMP INHIBITOR
    GCN 28572
    HICL Sequence Number 036964
    HICL Sequence Number Description NAPROXEN/ESOMEPRAZOLE MAGNESIUM
    Brand/Generic Generic
    Proprietary Name NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
    Proprietary Name Suffix n/a
    Non-Proprietary Name NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 20; 375
    Active Ingredient Units mg/1; mg/1
    Substance Name ESOMEPRAZOLE MAGNESIUM; NAPROXEN
    Labeler Name Lupin Pharmaceuticals, Inc.
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA AUTHORIZED GENERIC
    Application Number NDA022511
    Listing Certified Through n/a

    Package

    NDC 70748-0215-07 (70748021507)

    NDC Package Code 70748-215-07
    Billing NDC 70748021507
    Package 60 TABLET, DELAYED RELEASE in 1 BOTTLE (70748-215-07)
    Marketing Start Date 2020-03-04
    NDC Exclude Flag N
    Pricing Information N/A